RFA Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with RFA Plus Lyso-thermosensitive Liposomal Doxorubicin

PURPOSE: To test the hypothesis that the Burn time Per tumor Volume (BPV, min/ml), where burn time is the total time during which radiofrequency energy is being applied, is correlated with outcomes in the treatment of the hepatocellular carcinoma (HCC) using radiofrequency ablation (RFA) plus lyso-t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Vasc Interv Radiol
Autors principals: Celik, Haydar, Wakim, Paul, Pritchard, William F., Castro, Meryll, Leonard, Shelby, Karanian, John W., Dewhirst, Mark W., Lencioni, Riccardo, Wood, Bradford
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875689/
https://ncbi.nlm.nih.gov/pubmed/31409568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvir.2019.04.023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars